{"id":1175,"slug":"svf和医院说的-干细胞注射-干细胞回输-是一回事吗","question":"SVF和医院说的“干细胞注射”“干细胞回输”是一回事吗？","intent":"informational","language":"zh","url":"https://worldwiki.io/q/svf和医院说的-干细胞注射-干细胞回输-是一回事吗","entity":{"slug":"stromal-vascular-fraction","name":"Stromal Vascular Fraction","url":"https://worldwiki.io/entity/stromal-vascular-fraction"},"answer":{"short_answer":"不是同一个概念。SVF 是脂肪去除成熟脂肪细胞后得到的异质性细胞混合物，里面除了基质／干细胞，还有血管内皮细胞、周细胞、免疫细胞和成纤维细胞，并非纯化的干细胞产品。它也不经过体外培养扩增，这一点与需要培养的脂肪来源干细胞（ADSC）不同。如果机构把 SVF 直接称作“干细胞注射”，应要求对方书面写明实际输入的是哪种细胞制备物。","detailed_answer":"<p>SVF（基质血管组分）来自抽脂取得的脂肪组织，经酶消化或机械／超声处理后去除成熟脂肪细胞，剩余的即为 SVF。文献层面的定义明确：它是<strong>异质性细胞群</strong>，干细胞只占其中一部分，因此不能等同于“纯化干细胞”。</p><p>与 ADSC 的核心差别是培养：SVF 是新鲜分离、当次使用，不做体外培养扩增；ADSC 需要在实验室培养。培养与否会直接影响细胞数量、纯度、所需时间，也常常影响各国的监管归类。</p><p>面诊时可以直接问三句：输入的是新鲜分离的 SVF 还是培养后的细胞？用的是酶消化还是机械／超声处理？有没有书面的制备与检测记录？</p>","format":"paragraph","confidence":55,"verified_at":null,"updated_at":"2026-09-20 17:11:10"},"sources":[{"id":20,"title":"Safety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review","url":"https://pubmed.ncbi.nlm.nih.gov/41618435/","publisher":"Stem Cell Research & Therapy (2026)","type":"academic","accessed_at":"2026-09-19 18:01:00"},{"id":14,"title":"ISSCR Guidelines for Stem Cell Research and Clinical Translation","url":"https://www.isscr.org/guidelines","publisher":"International Society for Stem Cell Research","type":"organization","accessed_at":"2026-09-19 18:01:07"}],"published_at":"2026-09-20 08:11:10"}